Table 2 Comparison of the serum indicators among patients classified by CDAI scores and controls.

From: Decreased serum iron concentration and total iron binding capacity are associated with serious Crohn’s disease

 

Remission

(n = 15)

Mild

(n = 16)

Moderate

(n = 53)

Control

(n = 24)

p value

Iron (µmol/L)

10.50a,b

(8.50,14.30)

7.65a

(5.55,10.78)

5.60a

(3.80,9.60)

16.15

(14.15,22.25)

0.00

TIBC (µmol/L)

53.29 ± 11.58b

52.23 ± 13.01b

43.67 ± 9.34a

53.58 ± 9.81

0.00

Ferritin (ug/L)

124.80

(56.80,200)

66.60

(39.85,187.20)

88.10

(47.95,212.75)

207.65

(62, 323.68)

0.182

Transferrin (g/L)

2.32b

(1.91,2.72)

2.12

(1.78,2.67)

1.87a

(1.62,2.12)

2.15

(2.03,2.50)

0.00

Transferrin saturation (%)

27

(15,33)

16a

(11,22.25)

14a

(9, 21.75)

32

(25.5,44)

0.00

  1. TIBC: total iron binding capacity.
  2. For TIBC: One-way ANOVA.
  3. For the other parameters: Kruskal–wallis H test.
  4. p < 0.05 means that the distribution of values in each group is not equal.
  5. The letter a means that the difference is significant when compared to the controls separately.
  6. The letter b means that the difference is significant when compared to the moderate group separately.